Humana Inc. (NYSE:HUM) Shares Acquired by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd lifted its holdings in Humana Inc. (NYSE:HUM) by 32.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,227 shares of the insurance provider’s stock after purchasing an additional 2,770 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Humana were worth $2,848,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Transcend Capital Advisors LLC boosted its holdings in Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after acquiring an additional 2,914 shares in the last quarter. FNY Investment Advisers LLC boosted its stake in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after purchasing an additional 26,856 shares in the last quarter. Retirement Systems of Alabama grew its position in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in Humana by 7.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after purchasing an additional 65,735 shares in the last quarter. Finally, PDT Partners LLC raised its holdings in shares of Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after buying an additional 2,660 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HUM has been the topic of a number of research analyst reports. Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. JPMorgan Chase & Co. cut their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Barclays lifted their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Finally, Truist Financial raised their price target on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Eighteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Stock Down 2.4 %

Shares of NYSE HUM opened at $263.95 on Friday. The firm has a market cap of $31.86 billion, a price-to-earnings ratio of 26.53, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company’s 50-day simple moving average is $270.14 and its 200-day simple moving average is $273.87. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.34%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.37% of the stock is currently owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.